Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)

NCT04940000 | Recruiting

• 1 other identifier: 21VADS03
• Study Type: interventional
• Target: 105
• Locations: 1 country
• Sites: 1

Brief Summary

Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems. The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy. Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire. At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.

Conditions

ORL Cancer

Keywords

Video-Assisted Speech Therapy

Outcome Measures

Primary Outcomes (1)

• The rate of patients for whom tele-therapy will be considered successful.

  12 months for each patient

Secondary Outcomes (1)

• The rate of patients with full or partial resolution of speech-language pathology at the end of the telecare consultation.

  12 months for each patient

Study Arms (1)

Patient with T3-T4 ORL cancer, relevant to surgery and/or radiotherapy and/or chemotherapy.

EXPERIMENTAL

Other: Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).

Interventions

Patient managed at the IUCT-O and by a private speech therapist (near the patient's home). OTHER

Each patient included will have a video-assisted remote speech therapy consultation with a private speech therapist (near the patient's home) and the expert speech therapist of IUCT-O center. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire.

Patient with T3-T4 ORL cancer, relevant to surgery and/or radiotherapy and/or chemotherapy.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age ≥ 18 years at study entry.
• Patient with carcinological pathology of the VADS, relevant to surgery and/or radiotherapy and/or chemotherapy.
• Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
• Patient affiliated to a Social Security system in France.

You may not qualify if:

• Pregnant or lactating women.
• Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol.
• Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).

Sponsors & Collaborators

• Institut Claudius Regaud: lead

Study Sites (1)

Institut Universitaire du Cancer de Toulouse - Oncopole

Toulouse, France

RECRUITING

Central Study Contacts

Jérôme SARINI

CONTACT

05 31 15 60 16; sarini.jerome@iuct-oncopole.fr

Jean-Claude FARENC

CONTACT

05 31 15 51 97; farenc.jean-claude@iuct-oncopole.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 17, 2021
• First Posted: June 25, 2021
• Study Start: September 2, 2021
• Primary Completion (Estimated): September 1, 2028
• Study Completion (Estimated): September 1, 2028
• Last Updated: July 31, 2025

Record last verified: 2025-07

Locations

FR (1)